Jayne Crisman

Jayne Crisman is a Senior Analyst covering the Communication Services & Technology sector. Prior to joining Tech Insider in 2000, she worked at J.C. Bradford & Co. and Hoak Breedlove Wesneski & Co. covering wireless communications, and at Fidelity Investments before that. She is a five-time winner of the Wall Street Journal’s “Best on the Street” analysts survey, including ranking No. 1 in 2012 in the Telecommunications Equipment category.

Trader’s Recap : Tesla Motors Inc (NASDAQ:TSLA), U.S. Bancorp (NYSE:USB), Knowles Corporation (NYSE:KN), Mizuho Financial Group, Inc. (NYSE:MFG), Marine Products Corp. (NYSE:MPX)

Tesla Motors Inc (NASDAQ:TSLA) has created electric cars that are rapidly dropping in price and will soon be available to the average American. Entrepreneurs, not government, created these incredible advances of technology. Tesla Motors Inc (NASDAQ:TSLA) belongs to Consumer Goods sector. Its net profit margin is -6.80% and weekly performance is 6.96%. On last trading…

Read More

Top News : Arch Coal Inc. (NYSE:ACI), ArcelorMittal SA (ADR) (NYSE:MT), W. P. Carey Inc. (NYSE:WPC), Digital Power (NYSEMKT:DPW), Celldex Therapeutics (NASDAQ:CLDX)

Arch Coal Inc. (NYSE:ACI) is requesting that more than 300 acres of agricultural land be reclassified in order to expand an existing coal-waste storage facility.  The board would have to approve the zoning board’s decision. Arch Coal Inc. (NYSE:ACI) belongs to Basic Materials sector. Its net profit margin is -24.30% and weekly performance is -23.58%….

Read More

Why Making Dramatic Moves : Ruthigen, Inc. (NASDAQ:RTGN), Rite Aid Corporation (NYSE:RAD), ION Geophysical Corporation (NYSE:IO), Guidance Software, Inc. (NASDAQ:GUID), Graham (NYSE:GHM)

Ruthigen Inc (NASDAQ:RTGN) in the last week of August announced that it had received approval for Phase I/II Study. It can begin enrollment of patients in its trial meant to test its anti-infection drug RUT58-60. It has already completed a 21-day skin irritation study conducted on 36 human participants, and now will start with double-blind,…

Read More

Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in…

Read More

Morning Alert : Nabors Industries Ltd. (NYSE:NBR), Nokia Corporation (ADR) (NYSE:NOK), JEC, Elbit Systems Ltd. (NASDAQ:ESLT), Joe’s Jeans Inc. (NASDAQ:JOEZ)

Nabors Industries (NYSE:NBR) has earned an average rating of “Buy” from the twenty-three ratings firms that are presently covering the stock, American Banking and Market News reports. Six investment analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 1-year target price among brokerages…

Read More

Top Stories : Fifth Third Bancorp (NASDAQ:FITB), Cytori Therapeutics, Inc. (NASDAQ:CYTX), Premiere Global Services, Inc. (NYSE:PGI), Apple Inc. (NASDAQ:AAPL), Century Casinos (NASDAQ:CNTY)

On Sep 24, Fifth Third Bancorp (NASDAQ:FITB) has announced the formation of the Payments and Commerce Solutions division. The new division was created to rethink the payment and commerce experience with innovation that delivers greater value to customers. The organization is led by Randy Koporc, executive vice president and head of Fifth Third Payments and…

Read More